- Record: found
- Abstract: found
- Article: not found
Cost-effectiveness of screening for HIV in the era of highly active antiretroviral therapy.
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
The costs, benefits, and cost-effectiveness of screening for human immunodeficiency virus (HIV) in health care settings during the era of highly active antiretroviral therapy (HAART) have not been determined.